These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21459118)

  • 21. Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands.
    Gavioli EC; Calo' G
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Feb; 372(5):319-30. PubMed ID: 16491387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of nociceptin/orphanin FQ receptor ligands on blood pressure, heart rate, and plasma catecholamine concentrations in guinea pigs.
    Hashiba E; Hirota K; Kudo T; Calo' G; Guerrini R; Matsuki A
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):342-7. PubMed ID: 12690425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test.
    Gavioli EC; Marzola G; Guerrini R; Bertorelli R; Zucchini S; De Lima TC; Rae GA; Salvadori S; Regoli D; Calo G
    Eur J Neurosci; 2003 May; 17(9):1987-90. PubMed ID: 12752799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of amygdaloid nuclei in the anxiolytic-like effect of nociceptin/orphanin FQ in rats.
    Uchiyama H; Toda A; Hiranita T; Watanabe S; Eyanagi R
    Neurosci Lett; 2008 Jan; 431(1):66-70. PubMed ID: 18166271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of [Arg14, Lys15] nociceptin/orphanin FQ, a highly potent agonist of the NOP receptor, on in vitro and in vivo gastrointestinal functions.
    Broccardo M; Linari G; Guerrini R; Agostini S; Petrella C; Improta G
    Peptides; 2005 Sep; 26(9):1590-7. PubMed ID: 16112397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The nociceptin/orphanin FQ-NOP receptor antagonist effects on an animal model of sepsis.
    Carvalho D; Petronilho F; Vuolo F; Machado RA; Constantino L; Guerrini R; Calo G; Gavioli EC; Streck EL; Dal-Pizzol F
    Intensive Care Med; 2008 Dec; 34(12):2284-90. PubMed ID: 18846364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The anxiolytic-like effects of the novel, orally active nociceptin opioid receptor agonist 8-[bis(2-methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510).
    Varty GB; Lu SX; Morgan CA; Cohen-Williams ME; Hodgson RA; Smith-Torhan A; Zhang H; Fawzi AB; Graziano MP; Ho GD; Matasi J; Tulshian D; Coffin VL; Carey GJ
    J Pharmacol Exp Ther; 2008 Aug; 326(2):672-82. PubMed ID: 18492950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder.
    Zhang Y; Simpson-Durand CD; Standifer KM
    Br J Pharmacol; 2015 Jan; 172(2):571-82. PubMed ID: 24666365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor.
    Calo G; Guerrini R; Rizzi A; Salvadori S; Burmeister M; Kapusta DR; Lambert DG; Regoli D
    CNS Drug Rev; 2005; 11(2):97-112. PubMed ID: 16007234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of pancreatic secretion in vitro by nociceptin/orphanin FQ and opioid receptors: a comparative study.
    Linari G; Agostini S; Broccardo M; Petrella C; Improta G
    Pharmacol Res; 2006 Nov; 54(5):356-60. PubMed ID: 16979347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-dose Nociceptin/Orphanin FQ reduces anxiety-like performance in alcohol-withdrawn, but not alcohol-naïve, Male Wistar rats.
    Aujla H; Nedjadrasul D
    Neuropharmacology; 2015 Jun; 93():1-6. PubMed ID: 25617519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nociceptin/orphanin FQ receptor knockout rats: in vitro and in vivo studies.
    Rizzi A; Molinari S; Marti M; Marzola G; Calo' G
    Neuropharmacology; 2011 Mar; 60(4):572-9. PubMed ID: 21184763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1-Benzyl-N-[3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl]pyrrolidine-2-carboxamide (Compound 24) antagonizes NOP receptor-mediated potassium channel activation in rat periaqueductal gray slices.
    Liao YY; Trapella C; Chiou LC
    Eur J Pharmacol; 2009 Mar; 606(1-3):84-9. PubMed ID: 19374842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NOP Ligands for the Treatment of Anxiety and Mood Disorders.
    Gavioli EC; Holanda VAD; Ruzza C
    Handb Exp Pharmacol; 2019; 254():233-257. PubMed ID: 30535941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The nociceptin system and hippocampal cognition in mice: a pharmacological and genetic analysis.
    Kuzmin A; Madjid N; Johansson B; Terenius L; Ogren SO
    Brain Res; 2009 Dec; 1305 Suppl():S7-19. PubMed ID: 19782658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of the acute and chronic estrogen on anxiety in the elevated T-maze.
    Kalandakanond-Thongsong S; Daendee S; Srikiatkhachorn A
    Physiol Behav; 2012 Jan; 105(2):357-63. PubMed ID: 21907223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands.
    Guerrini R; Caló G; Lambert DG; Carrá G; Arduin M; Barnes TA; McDonald J; Rizzi D; Trapella C; Marzola E; Rowbotham DJ; Regoli D; Salvadori S
    J Med Chem; 2005 Mar; 48(5):1421-7. PubMed ID: 15743186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nociceptin/orphanin FQ modulates motor behavior and primary motor cortex output through receptors located in substantia nigra reticulata.
    Marti M; Viaro R; Guerrini R; Franchi G; Morari M
    Neuropsychopharmacology; 2009 Jan; 34(2):341-55. PubMed ID: 18418358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral anti-nociceptive effect of nociceptin/orphanin FQ in inflammation and stress-induced colonic hyperalgesia in rats.
    Agostini S; Eutamene H; Broccardo M; Improta G; Petrella C; Theodorou V; Bueno L
    Pain; 2009 Feb; 141(3):292-299. PubMed ID: 19147291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs.
    Gavioli EC; Calo' G
    Pharmacol Ther; 2013 Oct; 140(1):10-25. PubMed ID: 23711793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.